BioLife Solutions to Present at Upcoming Investor Conferences

BOTHELL, Wash., Oct. 18, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, today announced that CEO Mike Rice and CFO Roderick de Greef will be attending and presenting at the following investor conferences:

• October 25^th at 2:00PM; Cavendish Global New York Health Impact Forum. New York Athletic Club (City House); Session Title: Ground Breaking Discoveries and Innovations.  For more information please visit http://cavendishglobal.com/2017-nyc/
  
  
• November 16^th at 3:00PM; Furey Research Partners Hidden Gems Investor Conference. The University Club, New York. For more information please visit https://www.eventbrite.com/e/furey-research-partners-hidden-gems-conference-2017-tickets-38498157024?aff=erelexpmlt
  
  
• December 5^th at 1:00PM; LD Micro 10^th Annual Main Event. Luxe Sunset Boulevard Hotel, Los Angeles. For more information please visit https://www.ldmicro.com/events

About BioLife Solutions

BioLife Solutions is the leading developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. Our proprietary HypoThermosol^® and CryoStor^® platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. Our biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function.

For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

Media & Investor Relations
Roderick de Greef
Chief Financial Officer
(425) 686-6002
[email protected]

SOURCE BioLife Solutions, Inc.